Page Content
Pramo Molecular
- © Pramo Molecular
Delivering Nucleic Acid Drugs
Team:
Merle Fuchs
(PhD, Dipl. Biol. Molecular Biology)
Project Management, Strategic Planning, Financing
Mona Fechler Bitteti
(M.Sc. Molecular Biology)
Quality Control
Ida Shaef
(M.Sc. Biological Chemistry)
Leader 3D Organ Models
Thomas Hiller
(PhD, M.Sc. Biotechnology)
Technical Leader
Sector:
Biotechnology/Pharma
Mentor:
Prof. Jens Kurreck, PhD, Applied Biochemistry
Faculty:
Faculty III – Process Sciences
Institute of Biotechnology
Department of Applied Biochemistry
Support:
EXIST-Forschungstransfer: 10.2019 – 09.2020
Delivery systems for nucleic acid based drugs
- © Pramo Molecular
Our idea
Pramo Molecular ("pramo" = "ferry" in Esperanto), develops covalently bound carrier molecules that transport therapeutic oligonucleotides like siRNA or antisense DNA into the target cells in a particularly efficient and compatible manner.
Transport problems across lipid membranes have prevented the use of nucleic acid agents to treat serious infectious, metabolic or cancer diseases. Pramo Molecular´s delivery molecules are particularly easy to manufacture in compliance with pharmaceuticals.
During our preclinical development we are also using humanized and murine 3D tissue models to limit animal testing.